Overview

Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Objective: The objective of this pilot study is to characterize the cardiac uptake patterns of I-123 mIBG in stress-induced (Takotsubo's) cardiomyopathy. Hypothesis: Perturbations in sympathetic innervation are the underlying pathogenesis of stress induced cardiomyopathy and will result in abnormalities in I-123 mIBG cardiac imaging. Thus, planar and SPECT I-123 MIBG imaging will provide insight into the pathogenesis of stress-induced cardiomyopathy, and may lead to the development of more specific diagnostic criteria. Study design: This proposal is for a prospective pilot study to characterize perturbations in cardiac sympathetic innervation in patients with stress induced cardiomyopathy by performing planar and SPECT I-123 MIBG imaging during the acute presentation and after recovery of LV function.
Phase:
N/A
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
GE Healthcare
Treatments:
3-Iodobenzylguanidine